Philip G. Conaghan
Philip G. Conaghan publishes mostly in Rheumatology, Surgery and Orthopedics and Sports Medicine, on topics such as Rheumatoid Arthritis Research and Therapies, Osteoarthritis Treatment and Mechanisms and Spondyloarthritis Studies and Treatments.
- World rank
- #66,017 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #5,593 of 367,258
- Works
- 1,146
- Citations
- 56k
- Citations per work
- 48.4
What does Philip G. Conaghan research?
Philip G. Conaghan's work is mostly in Medicine (69%), Immunology and Microbiology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences78768.7%
- Medicine78768.7%
- Everything else33329.1%
- Life Sciences252.2%
- 1Rheumatology44% of their works
- 2Surgery13% of their works
- 3Orthopedics and Sports Medicine5% of their works
- 4Pharmacology4% of their works
- 5Hematology3% of their works
- 6Immunology2% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Osteoarthritis Treatment and Mechanisms
- Spondyloarthritis Studies and Treatments
- Total Knee Arthroplasty Outcomes
- Systemic Lupus Erythematosus Research
- Bone and Joint Diseases
- Autoimmune and Inflammatory Disorders Research
- Inflammatory mediators and NSAID effects
Which keywords describe Philip G. Conaghan's research?
The keywords of their largest research topics: Inflammation, Autoantibodies, Cardiovascular Risk, Biological Therapy, Rheumatoid Arthritis, Cartilage, Osteoarthritis and Ankylosing Spondylitis.
- Cancer
- Hemophagocytic Lymphohistiocytosis
- Femoral Head
- Antiphospholipid Syndrome
- Arthroplasty
- Ankylosing Spondylitis
- Cartilage
- Biological Therapy
- Autoantibodies
- Inflammation
- Cardiovascular Risk
- Rheumatoid Arthritis
- Osteoarthritis
- Spondyloarthritis
- Total Knee Replacement
- Systemic Lupus Erythematosus
- Osteonecrosis
- Juvenile Idiopathic Arthritis
- Cyclooxygenase-2 Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Inflammation1,0473 topics
- Autoantibodies6822 topics
- Cardiovascular Risk6492 topics
- Biological Therapy5741 topic
- Rheumatoid Arthritis5741 topic
- Cartilage3981 topic
- Osteoarthritis3981 topic
- Ankylosing Spondylitis2191 topic
- Spondyloarthritis2191 topic
- Arthroplasty1321 topic
- Total Knee Replacement1321 topic
- Antiphospholipid Syndrome1081 topic
- Systemic Lupus Erythematosus1081 topic
- Femoral Head1051 topic
- Osteonecrosis1051 topic
- Hemophagocytic Lymphohistiocytosis801 topic
- Juvenile Idiopathic Arthritis801 topic
- Cancer751 topic
- Cyclooxygenase-2 Inhibitors751 topic
Where does Philip G. Conaghan work?
Philip G. Conaghan's main affiliation in the publication record is University of Leeds, United Kingdom.
How many publications and citations does Philip G. Conaghan have?
OpenAlex counts 1,146 works and 55,518 citations for Philip G. Conaghan, an h-index of 116, ranking #66,017 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Philip G. Conaghan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.